TBX2 and breast carcinoma: In discrepancy with our results, previous studies have indicated that TBX2 knockdown in MCF7 breast carcinoma and human melanoma cell models did not diminish tumor cell invasion [69], [74] or repress endogenous E-cadherin expression [69].